sharkwatertrading

(It's very urgent, hence we kindly ask you to pass this message to your CEO. In case you think this has been emailed to you wrongly, please ignore it. Thank you.)
Dear CEO,
We are the domain name registration service company in Shanghai, China. On October 22, 2026, we received an application from Jiazhi Ltd. They wish to register "sharkwatertrading" as their internet keyword and Chinese domains (sharkwatertrading.cn, sharkwatertrading.com.cn, sharkwatertrading.net.cn, sharkwatertrading.org.cn). But after we review it, we find this name conflicts with your business name or brand name. To resolve this situation better, it's necessary to send a message to you and confirm if this firm is your distributor in China?

 

Best regards

---

Kenny Liu

General Manager

Tel: +86-2161918696 | Fax: +86-2161918697 | Mob: +86-13816428671

12F Kaike Building, No. 1801 Hongmei Road, Shanghai 200233, China

SharkWater Trading  •  Space Desk • Company Update Rocket Lab Pushed Neutron's First Launch to 2027, and the Release Gives No New Date and No Reason October 21, 2026 Bottom Line Up Front Rocket Lab (Nasdaq: RKLB) said in a media release dated October 14, 2026 that Neutron’s inaugural launch “is now expected to occur in 2027.” The release gives no month, no reason and no financial figures. A secondary report (24/7 Wall St., October 15) puts RKLB near $52.85 intraday on October 15 after an 8% drop the day before, and attributes the cause to dome manufacturing issues. I could not confirm that cause in a primary document. The primary-source fact is the slip. Everything else on this page is labeled secondary. What the Primary Source Says The release, furnished as Exhibit 99.1 to a Rocket Lab 8-K, is titled “Rocket Lab Provides Update on Neutron Development and Adjusted Target Launch Timing.” It points readers to an investor presentation on Rocket Lab’s IR site for detail. I did not retrieve that presentation, so the reasons and any revised test schedule are NOT VERIFIED here. Source: Rocket Lab Exhibit 99.1, sec.gov, dated 2026-10-14. EDGAR submissions feed for CIK 1819994 as read 2026-10-21 listed no filing after 2026-10-02, so the feed lagged this 8-K. Treat feed completeness for RKLB as unreliable. What Is Secondary and Unconfirmed The 24/7 Wall St. piece (October 15, 2026) says RKLB fell about 11% in morning trading to $52.85 after dropping 8% to $59.18 the day before, and that the stock was down 23% year to date. It also relays that the CEO described voids in carbon composite layers of a propellant dome and that cryogenic and hydrostatic testing would run into Q1 2027. Those quotes are not in the release I read, and the article is internally inconsistent on the size of the move (11% versus 9%). I am not repeating them as fact. Pull the 8-K presentation and the call transcript before leaning on any of it. Source: 24/7 Wall St., 2026-10-15 (aggregator, secondary). Prices not verifiable against an exchange source this run. Why It Still Matters Six Days Later Neutron is the program the medium-lift thesis hangs on. A 2027 date pushes the first revenue launch further out and moves the cash-flow story with it. An earlier desk note (September 7) logged an August investor-call warning that launch risk could slide into 2027, so the market had a partial heads-up. A date is now on paper, and the paper has no month on it. A launch date with no month is a tide table with the hours torn off. You know the water is coming. You do not know when to set the pots. The Bull Case The slip is now priced in the record. Management put 2027 in writing rather than let a Q4 date die quietly. Electron keeps flying. The desk logged the 97th Electron mission on September 25, 2026 from Rocket Lab’s own release, so the cash-generating business is operating. The reason, if secondary reports are right, is a manufacturing fix, not a design failure. Unconfirmed, but it would be the better of the two outcomes. The Bear Case No month, no reason in the release. An undated 2027 can mean January or December, and the market will price the worse end. Cash flow is tied to Neutron. Per the secondary report, the CFO linked cash-flow improvement to a successful first launch. That claim is NOT VERIFIED here, but if true, every quarter of delay extends the burn. Disclosure lag. The 8-K did not show in the EDGAR feed within a week. Anyone screening filings by feed alone missed it. The SharkWater Take The slip is real and sourced. The reasons are not. I am not trading RKLB off a release that tells me less than the stock chart did. If the investor presentation shows a hard test schedule with dates, the setup becomes analyzable. Until then it is a name where the bad news is known and the size of it is not. That is a pass for me today. The one thing worth doing: read the presentation, then decide whether 2027 means early or late. Execution notes: none. No options data was pulled this run and no premiums are quoted. Tight lines, SharkWater Educational and informational purposes only. Not personalized investment advice. All figures sourced as noted and accurate as of publication. The author may hold positions in securities discussed. Do your own work.

SharkWater Trading  •  Data Center Desk • Insider Filing Nebius Director Arne Grimme Bought 148 Shares at Exactly $169.99 for the Third Straight Session, and the Price Never Moved October 20, 2026 Bottom Line Up Front A Form 4 filed today (October 20, 2026) shows Nebius (Nasdaq: NBIS) director Arne Grimme bought 148 shares at $169.99 on October 19, his third consecutive daily purchase at that exact price. He now holds 6,329 direct shares, up from 5,885 before the October 15 buy (desk math: 3 x 148 = 444). Every purchase is tagged to a Rule 10b5-1 plan adopted June 15, 2026. The notional is about $25,000 per day at 148 shares (desk calc). The same price three days running is the data point. The filing does not say why, and I have no live quote to compare it to. What the Filing Shows Item Per Form 4 filed Oct 20, 2026 Reporting person Arne Grimme, Director Transaction date October 19, 2026, code P (open market purchase) Shares and price 148 at $169.99, acquired, direct Direct shares after 6,329 10b5-1 Box checked. Footnote: plan adopted June 15, 2026 Signed October 20, 2026, attorney-in-fact (Anna Akimova) Source: SEC EDGAR Form 4, accession 0001513845-26-000134, filed 2026-10-20. Notional and share-count arithmetic are desk calculations, not a market quote. Three Days, One Price Grimme’s earlier Form 4 (accession 0001513845-26-000130, filed 2026-10-16) reported two buys of 148 shares at $169.99, on October 15 and October 16. Today’s filing adds October 19. That is 444 shares at one printed price across three sessions. Our October 19 post showed a different director, John Boynton IV, selling across a $164.80 to $188.77 band on October 15. A stock that traded a $23.97 range on October 15 and then filled the same buyer at $169.99 again on October 16 and October 19 is not behaving like a market order. The filing does not state a limit price, and I am not going to invent one. The pattern is consistent with a plan that triggers at or below a set price, but that is my inference, not a filed fact. If it is right, it also tells you the stock traded at or below $169.99 on each of those sessions. That is what to check on a chart. A plan buyer with a fixed limit is a crab pot dropped at one depth. It only fills when the tide brings the price down to it, so each fill tells you where the water was. Company News the Same Day Nebius’s own newsroom lists a blog post dated October 19, 2026: $10 million in compute, capital and community programs for European AI builders. It is a program announcement, not a financial update, and I found no 8-K or 6-K tied to it. The last press release on the page is the Inferize acquisition dated October 1, 2026. Nothing there explains the October 15 price range. Source: nebius.com/newsroom, read 2026-10-20. The Bull Case The buyer kept buying. $25,000 a day is small, but the plan was adopted in June and keeps executing through a drawdown. Fills mark a level. Directors do not control the plan once it is adopted, so these fills are a mechanical floor marker, not sentiment. Both holdings remain. Grimme is up to 6,329 direct shares. Boynton still holds 403,522 after his sale. The Bear Case Size is trivial. 444 shares is roughly $75,000 total (desk calc at $169.99). It is a rounding error against the Boynton sale. Plan, not conviction. A plan set in June that keeps buying at one price says nothing about what the board knows today. Cause unexplained. No 8-K, 6-K or press release explains the October 15 swing. The cause is still missing. The SharkWater Take This is a footnote, not a thesis. Three identical-price fills tell me where the stock has been trading, not where it is going, and a $75,000 plan purchase does not offset the insider paper that has stacked up on this name. I am not trading it. Pull the October 15, 16 and 19 sessions on your own chart and see whether $169.99 was the low or just a level the stock kept revisiting. If it held, that is a support marker worth watching. If it broke, the plan buyer is the one with the stale limit. I have no live quote, so I take no side today. Tight lines, SharkWater Educational and informational purposes only. Not personalized investment advice. All figures sourced as noted and accurate as of publication. The author may hold positions in securities discussed. Do your own work.

SharkWater Trading  •  Data Center Desk • Insider Filing Nebius Director's Trust Actually Sold 7,260 Shares Between $164.80 and $188.77, a 14.5 Percent Intraday Range, While Another Director Bought Under a Plan October 19, 2026 Bottom Line Up Front A Form 4 filed this morning (October 19, 2026) settles the question our October 16 post left open. Nebius (Nasdaq: NBIS) director John W. Boynton IV reported selling 7,260 shares on October 15 in 19 lots at weighted-average prices from $164.80 to $188.77. Desk math puts the blended price at $177.63 and gross proceeds near $1.29 million, about 4.5 percent under the $1.35 million the Form 144 estimated. The Form 144 implied $186.01. The real fills started lower and ended higher. A second director, Arne Grimme, bought 148 shares on each of October 15 and 16 at $169.99 under a plan adopted June 15, 2026. I have no verified cause for the October 15 range. What the Form 4 Shows Item Per Form 4 filed Oct 19, 2026 Seller John W. Boynton IV, Director (direct holding, signed by attorney-in-fact) Trade date October 15, 2026, code S (open market sale) Shares sold 7,260 across 19 weighted-average lots Lowest and highest lot price $164.80 (200 shares) and $188.77 (100 shares) Largest lot 960 shares at $188.20 Blended price (desk calc) $177.63 Gross proceeds (desk calc) $1,289,586 Direct shares after 403,522, down from 410,782 (1.8% of the position sold) 10b5-1 Affirmative checkbox marked. No footnote names a plan date. Source: SEC EDGAR Form 4, accession 0001513845-26-000132, filed 2026-10-19. Blended price, proceeds and percentages are desk calculations from filed lots, not a market quote. The Price Range Is the Story The lots are listed in rising price order, so the filing does not tell you the sequence of fills. It does tell you the stock traded across a $23.97 band, from $164.80 to $188.77, on a single session. That is a 14.5 percent spread from low to high. Our October 16 post flagged the Form 144 valuation of $186.01 as a possible 21 percent drop from the $235 print on September 29. The Form 4 says the stock was trading in the $165 to $189 zone on October 15, so the drop was real in the sense that sub-$190 prices printed. It still does not name a cause. I found no Nebius 8-K, 6-K or press release explaining it. Grimme’s purchases land inside the same zone. He bought 148 shares at $169.99 on October 15 and again on October 16, taking his direct holding from 5,885 to 6,181 shares. Footnote one says both were made under a Rule 10b5-1 trading plan adopted June 15, 2026. A matching price on two consecutive days is unusual. The filing does not explain it, and I will not guess at the mechanism. A plan seller is a boat on a trolling line. It keeps its speed whether the current runs fast or slow. The Form 4 is the log that finally shows how rough the water was while it passed. What the Two Directors Did Director Action Date Shares Price Plan Boynton Sold Oct 15 7,260 $164.80 to $188.77 10b5-1 flag set, no plan date in footnotes Grimme Bought Oct 15 148 $169.99 10b5-1, adopted Jun 15, 2026 Grimme Bought Oct 16 148 $169.99 10b5-1, adopted Jun 15, 2026 Source: SEC EDGAR Forms 4, accessions 0001513845-26-000132 (filed 2026-10-19) and 0001513845-26-000130 (filed 2026-10-16). The Form 144 filed 2026-10-15 (0001950047-26-010270) gave the 10b5-1 adoption date of 03/06/2026 for the Boynton sale. The Bull Case The sale is tiny. $1.29 million against roughly 238.4 million shares outstanding (Form 144 cover figure) is noise, and the plan predates the move by seven months. A director bought into the range. Grimme’s buys are small, about $25,000 a day at $169.99 (desk calc), but they ran two days straight at the low end of Boynton’s sale range. The position is intact. Boynton still holds 403,522 direct shares after the sale. The Bear Case A 14.5 percent intraday range with no filed cause. A wide range with no 8-K or 6-K behind it means the explanation sits somewhere other than EDGAR, and I have not found it. Insider paper keeps stacking. This follows the Nave plan sale, the October 1 withholding sales and the Goldman 13G/A cut covered earlier on this desk. Plan supply does not pause for price. 7,260 shares went out across a $165 to $189 session. The filing does not give the order of fills, so I cannot say whether the plan sold into weakness or strength. The SharkWater Take This is a pricing record, not a signal about the director. The sale is plan-driven and small, and I am not reading intent into it. What I wanted from the Form 4 was the real price, and I got it: NBIS traded from the mid-$160s to the high-$180s in one session. That volatility is the fact worth your time. Pull a live quote and an intraday chart from your broker, find the cause of the October 15 swing, and do not trade this filing. Until a cause shows up, I am taking no side on the stock. Tight lines, SharkWater Educational and informational purposes only. Not personalized investment advice. All figures sourced as noted and accurate as of publication. The author may hold positions in securities discussed. Do your own work.

SharkWater Trading  •  Market Desk • Weekend Brief The Chip Rout Ends the Week With No New Filings From the Eight Watchlist Names We Checked, Nasdaq Down 4.48 Percent, and Meta Reports Wednesday October 18, 2026 Bottom Line Up Front The Nasdaq Composite closed Friday at 26,140.03, down 4.48 percent on the week, and the SOXX chip ETF fell 4.14 percent on the day (TechStock² citing AP, press figures). The Cboe VIX printed 19.99, up from a 16.46 prior close (Cboe page, October 16, 2026). Today is Sunday, EDGAR takes no filings, and the eight filers we checked directly (NVDA, NBIS, MU, RKLB, ASTS, AVGO, OKLO, LUNR) show nothing newer than the last scan. The next hard catalyst is Meta's Q3 report after the close on Wednesday, October 21, confirmed on Meta's own investor site. What the Primary Sources Show Issuer Latest filing in EDGAR feed Filed Change since Oct 17 scan NVDA Accession 0002152188-26-000007 (form type not shown) 2026-10-13 None NBIS Form 144, 0001950047-26-010270 2026-10-15 None MU Forms 4 cluster, 0001242654-26-000016 and others 2026-10-15 None RKLB Form 4, 0002001011-26-000143 2026-10-02 None ASTS Form 4, 0001104659-26-104326 2026-09-01 None AVGO 0001104659-26-110983 (form type not shown) 2026-09-25 None OKLO Forms 424B5 and 8-K 2026-09-11 None LUNR Form 144, 0001968582-26-000989 2026-09-18 None Source: SEC EDGAR submissions feeds (data.sec.gov), read October 18, 2026. Where the feed omits form type, we say so rather than guess. A quiet filing tape after a hard Friday is information. The insiders who file on this watchlist did not add or dump anything over the weekend, which is what a closed regulator looks like. The next window opens with Monday morning Forms 4 and 144, and those will be the first filings written after Friday’s close. The Tape We Can Cite Measure Oct 16, 2026 Source Nasdaq Composite 26,140.03, -2.15% day, -4.48% week TechStock² citing AP (press) S&P 500 7,659.44, -1.09% day, -1.95% week TechStock² citing AP (press) SOXX -4.14% TechStock² (press) AMD / Intel / Micron / Broadcom -5.96% / -5.79% / -5.63% / -4.53% TechStock² citing AP (press) Cboe VIX 19.99, +3.53 (+21.45%), prior close 16.46 Cboe page, 8:15 PM, delayed 20+ min 10-year Treasury yield 5.09% TechStock² citing AP (press) Brent crude $109.86, +3.7% TechStock² citing AP (press) The TechStock² article is labeled AI-assisted. Its VIX figure of 20.16 differs from the Cboe page figure of 19.99, so we use Cboe. Only the VIX and Meta rows come from primary sources. A Friday gap with no weekend filings is a tide going out before anyone has checked the boats. You know the water moved. You do not yet know who was holding what. What Could Move It This Week Meta reports Q3 results after the close on October 21, with its call at 4:30 p.m. ET (Meta investor relations, release dated October 12, 2026). Meta fell 3.72 percent Friday in the sell-off per the press summary, and its capital spending guidance is the number the AI hardware names trade against. Tesla also reports that day per the same press summary, which we did not verify on Tesla’s site. The press summary also puts December rate-hike odds at 74.3 percent (CME data via AP), up from 50.2 percent a month earlier. That is not verified against CME directly. The Bull Case Friday was a flush, not a filing event. No insider dumping appeared in the eight feeds we read. The selling was macro, tied by AP to rates, oil and AI financing worries. The catalyst calendar is short and dated. Meta on Wednesday gives chip names a real data point instead of a rumor. The VIX is 19.99, not 35. A 21 percent one-day jump is sharp, but 19.99 is a level, not a panic print. The Bear Case The worst week since June. AP called it the worst week for both the S&P 500 and Nasdaq since June, per the press summary. Rates and oil are both pressing. A 5.09 percent 10-year and Brent near $110 hit the financing story that AI capex depends on. Monday brings a filing backlog. Forms 4 and 144 for trades made Thursday and Friday can post Monday morning, and a cluster of insider sales would land on a weak tape. The SharkWater Take I am taking no position off this tape. Nothing was filed, I have no verified quote on any watchlist name, and no options chain, so any trade idea would be invented. The disciplined read is to wait for Monday’s open and Monday’s filings, then see whether Meta on Wednesday confirms or breaks the AI-spend story. If the VIX holds near 20 and the chip complex stabilizes, Friday was a flush. If it climbs, the question changes. Tight lines, SharkWater Educational and informational purposes only. Not personalized investment advice. All figures sourced as noted and accurate as of publication. The author may hold positions in securities discussed. Do your own work.